Capital Allocation

Sunbelt hits record revenue, powered by its Specialty division and a key acquisition, but a closer look reveals margin pressure and operational challenges.

Sunstone sells the Hyatt Regency SF to Blackstone for $279M, a deal signaling a strategic shift for the REIT and a major bet on the city's comeback.

FMC's $114M sale-leaseback reflects a wider trend of monetizing real estate. We analyze the deal's impact on its debt, R&D, and what it signals for the market.

HLS Therapeutics is betting on itself with a larger share buyback. We analyze if this is a signal of deep value or a sign of limited growth opportunities.

Hyperscale Data builds a $46M Bitcoin treasury while planning a 590MW AI data center empire, forcing a strategic split and raising investor questions.

The mREIT just authorized a massive share repurchase, signaling deep confidence. But what does this move reveal about its strategy in a volatile RMBS market?

Vivos Therapeutics gets more time from its lender to raise capital, a crucial move as it navigates Nasdaq compliance issues and funds a major business overhaul.

Genius Group's massive share repurchase program aims to boost shareholder value, but a look at its financials reveals a high-stakes gamble. Is this a confident bet or a red flag?

Behind a routine financial announcement lies a masterclass in capital strategy. We dissect Great-West Lifeco's latest move and what it signals.

Leading Edge Materials holds Europe's rare earth keys, but a 'going concern' warning reveals a critical flaw in the continent's resource strategy.

XAI proposes a major sub-adviser shift for its XFLT and OCTIX funds to King Street Capital. What does this move mean for investors and the funds' strategy?

While crypto exchanges tout record trading on SpaceX derivatives, a behind-the-scenes failure to secure actual shares reveals a deep rift with traditional finance.

New data reveals a massive revenue gap in entertainment. Ignoring the U.S. Latino market isn't just an oversight—it's a quantifiable business disaster.

Saputo's divestiture of its volatile Argentine unit for $543M signals a strategic refocus on core markets, boosting its balance sheet and shareholder value.

The gas shipping giant just secured $206 million for new vessels, but the real story isn't the money—it's the sophisticated financial tool they used.

Alight's 1-for-20 reverse split aims to save its NYSE listing. Is this a savvy strategic reset or a temporary fix for a stock facing deeper challenges?

BioCardia bets its future on Japan's fast-track approval for its heart therapy, a strategic pivot that could unlock global markets or break the bank.

The grocery giant leans on booming eCommerce and marketing profits to offset cost pressures, reaffirming its yearly outlook in a show of strategic confidence.

MotoGP's massive debt repricing reduces costs by millions, showcasing Liberty Media's proven strategy to optimize sports assets and fuel future performance.

CONMED appoints John Gallagher, a seasoned MedTech CFO, to navigate market headwinds and drive a new chapter of financial performance and shareholder value.